Canadian biotech company Avivagen ready to enter US market

Canadian biotech company Avivagen ready to enter US market

Canadian biotech company Avivagen ready to enter US market

OxC-beta approval in the United States has opened business opportunities for the Canadian-based company

Canadian biotech and animal health company Avivagen has received more than $5 million in funding intended to increase its presence in the U.S. marketplace.  The company, based in Ottawa, Ontario, makes natural health products intended to replace antibiotics added to livestock feeds to promote productivity, particularly weight gain and feed conversion efficiency.  “Avivagen...